Index of /pdfs/QS I-Guage/Advanced Criterias/A1_Research (RE)/RE4_External research funding/MCA/Research Proposal

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]MCA_3.2_1_27_29.02-COV_CTA_Dr.Anand Nikalje_DNDi.pdf2024-09-18 08:06 97M 
[ ]MCA_3.2_1_11_13. George CTA_PI Dr Sudhir Kulkarni_MGM.pdf2024-09-18 08:05 26M 
[ ]MCA_3.2_1_3_05.Signed CTA_Amphotericin B_Dr Nikalje_MGM_Syngene (1).pdf2024-09-18 08:06 18M 
[ ]MCA_3.2_1_33_35.CTA_Alopecia Areata (2).pdf2024-09-18 08:06 17M 
[ ]MCA_3.2_1_32_34.PCV CTA Red Highlighted.pdf2024-09-18 08:06 17M 
[ ]MCA_3.2_1_28_30.CTA_ITOLI.pdf2024-09-18 08:06 16M 
[ ]MCA_3.2_1_18_20.CTA _Dr. Ashish Deshmukh Reliance.pdf2024-09-18 08:05 16M 
[ ]MCA_3.2_1_29_31.CTA_Glasshouse_JSS (3) (1).pdf2024-09-18 08:06 14M 
[ ]MCA_3.2_1_9_11.Biosulin CTA signed.pdf2024-09-18 08:06 12M 
[ ]MCA_3.2_1_26_28.CTA_DFU_MGM Aurangabad (1).pdf2024-09-18 08:06 11M 
[ ]MCA_3.2_1_21_23.CTA Ashish Deshmukh Zydus.pdf2024-09-18 08:05 11M 
[ ]MCA_3.2_1_20_22.CTA Rajendra Bohra Zydus.pdf2024-09-18 08:05 11M 
[ ]MCA_3.2_1_7_09.Oxygen SMO CTA (2).pdf2024-09-18 08:06 9.5M 
[ ]MCA_3.2_1_6_08.Bevacizumab CTA.pdf2024-09-18 08:06 9.3M 
[ ]MCA_3.2_1_10_12.promesa.pdf2024-09-18 08:05 8.2M 
[ ]MCA_3.2_1_8_10.CTA of Novartis Study (1).pdf2024-09-18 08:06 7.5M 
[ ]MCA_3.2_1_16_18.CTA of mgc - 006.pdf2024-09-18 08:05 7.0M 
[ ]MCA_3.2_1_34_36.CTA of Lupin.pdf2024-09-18 08:06 6.6M 
[ ]MCA_3.2_1_12_14.THB Signed CTA_merged.pdf2024-09-18 08:05 6.4M 
[ ]MCA_3.2_1_23_25.CTA AND FUNDING AGREEMENT URTI.pdf2024-09-18 08:05 6.1M 
[ ]MCA_3.2_1_24_26.SIGNED CTA.pdf2024-09-18 08:05 5.5M 
[ ]MCA_3.2_1_19_21.CSIR.pdf2024-09-18 08:05 5.0M 
[ ]MCA_3.2_1_13_15.CSIR.pdf2024-09-18 08:05 5.0M 
[ ]MCA_3.2_1_17_19.Signed CTA Hexa.pdf2024-09-18 08:05 4.7M 
[ ]MCA_3.2_1_22_24.CTA oF PRA.pdf2024-09-18 08:05 4.3M 
[ ]MCA_3.2_1_1_03.Parexel_ CTA.pdf2024-09-18 08:05 4.0M 
[ ]MCA_3.2_1_15_17.GSK CTA.pdf2024-09-18 08:05 3.1M 
[ ]MCA_3.2_1_4_06.CTA _HETERO_ Dr. Lakshmi.pdf2024-09-18 08:06 2.5M 
[ ]MCA_3.2_1_31_33.Scanned CTA IQVIA.pdf2024-09-18 08:06 2.2M 
[ ]MCA_3.2_1_2_04.CTA_Glenmark_Asthma.pdf2024-09-18 08:06 2.0M 
[ ]MCA_3.2_1_5_07.C2A00975_ CTA Amendment_Dr. Ashish Deshmukh (1).pdf2024-09-18 08:06 1.4M 
[ ]MCA_3.2_1_30_32.Amendment signed CTA_Lipiodol ..pdf2024-09-18 08:06 263K 
[ ]MCA_3.2_1_25_.27.BCR-RPD-NEON.pdf2024-09-18 08:05 243K 
[ ]MCA_3.2_1_14_16.Clinical Trial Agreement_GanjhuVir - 15.pdf2024-09-18 08:05 164K 
Apache/2.4.52 (Ubuntu) Server at mgmuhs.com Port 443